External broker reports(aggregated public sources), CMB International

CMB International

External broker reports(aggregated public sources)

Incorporated in Hong Kong, supported by the mainland and targeting in global market, CMB International Capital Corporation Limited (“CMBI”) is an integrated financial institution providing comprehensive and professional services. As a wholly-owned subsidiary of China Merchants Bank ("CMB"), by leveraging on the Group’s synergy and coordination in domestic and overseas markets, as well as CMB’s strong resources and outstanding social reputation, CMBI and its subsidiaries have been actively implementing diversified business strategies and set up an overall layout of main business segments including Corporate Finance, Asset Management, Wealth Management, Global Markets and Structured Finance, etc. Adhering to the philosophy of “being clients oriented and increasing our own values by the way of creating value for clients”, CMBI endeavors to provide quality and integrated financial services to institutional, corporate and individual customers both domestic and overseas including Hong Kong IPO sponsorship and underwriting, share placement and rights issue for listed companies, financial advisors, bonds issuance services, asset management, direct investment, wealth management, equity sales and trading, etc.

Equity Bottom-Up

<ul><li>A solid 2025; 1Q26 revenue slightly ahead of expectations. In 2025, MicroTech reported revenue of RMB3.2bn (+15.5% YoY) and attributable net profit of RMB570mn (+3.1% YoY).</li><li>Its 1Q26 revenue grew 22.1% YoY to RMB854mn, slightly beating our expectations and accounted for 24% of our full-year forecast (vs. the historical average of 21%).</li><li>Attributable net profit declined 9.0% YoY to RMB146mn primarily dragged by FX losses. </li></ul><p><em>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.</em></p>

A solid 2025; 1Q26 revenue slightly ahead of expectations. In 2025, MicroTech reported revenue of RMB3.2bn (+15.5% YoY) and attributable net profit of RMB570mn (+3.1% YoY).Its 1Q26 revenue grew 22.1% YoY to RMB854mn, slightly beating our expectations and accounted for 24% of our full-year forecast (vs. the historical average of 21%).Attributable net profit declined 9.0% YoY to RMB146mn primarily dragged by FX losses. Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Micro-Tech (688029 CH) - Robust overseas momentum and domestic recovery

China

Micro-Tech (Nanjing) Co., Ltd. manufactures and distributes medical equipment. The Company produces gastrointestinal equipment, biliary equipment, pulmonary equipment, and other related equipment. Micro-Tech (Nanjing) also operates import and export businesses.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Micro-Tech Nanjing (688029 CH)

Micro-Tech (688029 CH) - Robust overseas momentum and domestic recovery

A solid 2025; 1Q26 revenue slightly ahead of expectations. In 2025, MicroTech reported revenue of RMB3.2bn (+15.5% YoY) and attributable net profit...

CMB International

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)